PKTX (ProtoKinetix) OCF Margin %: 0.00% (As of Sep. 2025)


What is ProtoKinetix OCF Margin %?

ProtoKinetix PKTX +13.46% OCF Margin % is 0.00% as of Sep. 2025. The stock has 1 warning sign investors should review. Among 959 Biotechnology companies, ProtoKinetix ranks worse than 104275.18% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. ProtoKinetix's Cash Flow from Operations for the three months ended in Sep. 2025 was $-0.00 Mil. ProtoKinetix's Revenue for the three months ended in Sep. 2025 was $0.00 Mil. Therefore, ProtoKinetix's OCF Margin % for the quarter that ended in Sep. 2025 was 0.00%.

As of today, ProtoKinetix's current OCF Yield % is -7.84%.

The historical rank and industry rank for ProtoKinetix's OCF Margin % or its related term are showing as below:


PKTX's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

ProtoKinetix OCF Margin % Related Terms

ProtoKinetix OCF Margin % Historical Data

* Premium members only.

The historical data trend for ProtoKinetix's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ProtoKinetix OCF Margin % Chart

ProtoKinetix Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ProtoKinetix Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ProtoKinetix OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

ProtoKinetix's OCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-0.223/0
= %

ProtoKinetix's OCF Margin for the quarter that ended in Sep. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=-0.004/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
ProtoKinetix (PKTX) has a OCF Margin % of 0.00% as of Sep. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ProtoKinetix and its competitors. According to the industry distribution chart, ProtoKinetix ranks #999999 out of 959 companies in the Biotechnology industry.
Is ProtoKinetix's OCF Margin % too high?
ProtoKinetix's current OCF Margin % is 0.00%. Based on the distribution chart, ProtoKinetix ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does ProtoKinetix's OCF Margin % compare to BBLG and JAGX?
According to the Biotechnology industry distribution chart, ProtoKinetix ranks #999999 out of 959 companies for OCF Margin %. This places ProtoKinetix in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ProtoKinetix and its competitors. ProtoKinetix's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ProtoKinetix stock overvalued right now?
ProtoKinetix (PKTX) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For ProtoKinetix (PKTX), the current OCF Margin % is 0.00% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ProtoKinetix Business Description

Address 109 W Main Street, Dalton, OH, USA, 44618
ProtoKinetix Inc is a research and development stage biotechnology company focused on scientific medical research of AFGPs (Anti-Freeze Glycoproteins). The AFGP is a compound produced by fish, insects, reptiles, bacteria, and plants that enable survival in freezing temperatures. The company also develops AFGP applications which include regenerative medicine issues including harvesting, processing, storage, and transplanting cells, tissues, and organs and treatments for chronic inflammatory conditions and diseases caused by stress factors, including UV radiation, oxidation, and cryopreservation and hydrogen peroxide.